Product Program year 2023 Source: CMS Open Payments

T-Spot.Tb8

Device Diagnostic Test

PDI 15051716000305

Open in the dashboard

General payments

$45,373

192 payments

Research payments

$191,218

24 payments

Through program year 2023, $45,373 in general payments and $191,218 in research payments were reported against T-Spot.Tb8 (Diagnostic Test).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows

General

’22 ’23

Peak $29K

Research

’22 ’23

Peak $105K

Year	Kind	Amount	Payments
2023	General	$29,115	8
2023	Research	$86,468	12
2022	General	$16,258	184
2022	Research	$104,750	12

Breakdown

Who paid General payments · program years 2022–2023

Oxford Immunotec USA Inc $45,373 192 payments

Top recipients General payments · program year 2023

Paul Drain Infectious Disease · Seattle, WA $18,000 62% · 4 payments
Roy Chemaly Infectious Disease · Houston, TX $11,060 38% · 2 payments
Karen Kovalow-Stjohn Rheumatology · San Luis Obispo, CA $30 <1% · 1 payment
Elena Spektor Los Angeles, CA $25 <1% · 1 payment

Each share is of general payments naming this product in 2023.

Specialties paid General payments · program year 2023

Infectious Disease Internal Medicine $29,060 100% · 2 practitioners
Rheumatology Internal Medicine $30 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023

Washington $18,000 62% · 1 recipient
Texas $11,060 38% · 1 recipient
California $55 <1% · 2 recipients

Each share is of general payments naming this product in 2023 where a state was reported.

Records

192 general · 24 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.